Effect of the association between an inhibitor of cholinesterase and the cholinergic precursor choline alfoscerate on cognitive symptoms of Alzheimer's disease associated with vascular damage [Effetto dellassociazione tra un inibitore delle colinesterasi ed il precursore colinergico colina alfoscerato sui sintomi cognitivi e non della malattia di Alzheimer con danno vascolare associato]

Trial Profile

Effect of the association between an inhibitor of cholinesterase and the cholinergic precursor choline alfoscerate on cognitive symptoms of Alzheimer's disease associated with vascular damage [Effetto dellassociazione tra un inibitore delle colinesterasi ed il precursore colinergico colina alfoscerato sui sintomi cognitivi e non della malattia di Alzheimer con danno vascolare associato]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Nov 2012

At a glance

  • Drugs Choline alfoscerate (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms ASCOMALVA
  • Most Recent Events

    • 26 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top